Stock AMRX AMNEAL PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Amneal Pharmaceuticals, Inc.

Equities

AMRX

US03168L1052

Real-time Estimate Cboe BZX
Other stock markets
 10:02:44 2024-04-29 am EDT 		5-day change 1st Jan Change
5.88 USD +0.17% Intraday chart for Amneal Pharmaceuticals, Inc. +9.03% -3.54%
Apr. 24 Amneal Pharmaceuticals Cleared by FDA to Sell Generic Version of Nasal Spray to Treat Opioid Overdose -- Shares Rise MT
Apr. 24 Amneal Pharmaceuticals Shares Rise 9% After FDA Approves Naloxone Spray DJ

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Amneal Pharmaceuticals, Inc. Announces Management Changes
CI
Amneal Pharmaceuticals, Inc. Appoints Gustavo Pesquin as Executive Vice President, Chief Commercial Officer - Specialty
CI
Amneal Pharmaceuticals, Inc. Appoints Deborah M. Autor to Board of Directors
CI
CorMedix Names Joseph Todisco as CEO
MT
Joseph Todisco Step Down as Executive Vice President, Chief Commercial Officer of Amneal Pharmaceuticals, Inc
CI
Amneal Pharmaceuticals, Inc. Announces Retirement of Peter Terreri as Director
CI
Amneal Pharmaceuticals, Inc. Announces Management Changes
CI
Amneal Pharmaceuticals, Inc. Announces Board Appointments
CI
Amneal Pharmaceuticals, Inc. Appoints Paul M. Meister to the Board of Compensation Committee and Nominating and Corporate Governance Committee and Technology and Operational Compliance Committee
CI
Amneal Pharmaceuticals, Inc. Announces Management Changes
CI
Amneal Pharmaceuticals, Inc. Announces Management Changes
CI
Amneal Pharmaceuticals, Inc. Announces Management Changes
CI
Amneal Pharmaceuticals, Inc. Appoints Todd P. Branning as Senior Vice President and Chief Financial Officer to Replace Bryan Reasons
CI
Amneal Announces Executive Changes
CI
Amneal Pharmaceuticals, Inc. Announces Management Changes
CI
Amneal Pharmaceuticals LLC Announces Appointment of Andrew S. Boyer as Executive Vice President
CI
Amneal Pharmaceuticals Announces Executive Changes
CI
Amneal Pharmaceuticals, Inc. Announces Management Changes; Provides Earnings Guidance for the Year 2017 and 2018
CI
Amneal Pharmaceuticals LLC Appoints Sheldon Hirt as Senior Vice President and General Counsel, Effective September 13, 2016
CI
Amneal Pharmaceuticals LLC Appoints Rochelle Fuhrmann as Chief Financial Officer
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AMRX Stock
  4. News Amneal Pharmaceuticals, Inc.
  5. Insiders